HeartCore divests 51% Sigmaways stake, debt for up to $650k; reduces loss exposure

HeartCore Enterprises, Inc.

HeartCore sold 51% stake in Sigmaways and $2.19M in promissory notes for up to $650k ($1k cash + earn-out).
Sigmaways had a $3.6M shareholders' deficit as of March 31, 2026, and continued operating losses.
Company contributed a $350k SAFE note from Heart-Tech Health to Semaphore as additional consideration.
Earn-out is 10% of Sigmaways revenue over $5.5M within 12 months post-closing.
HeartCore now focuses on Go IPO consulting (3 engagements) and M&A advisory (2 engagements).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.